These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36647643)

  • 21. The Role of Oral Microbiota in Chronic Obstructive Pulmonary Disease.
    Wen S; Zhang Z; Ouyang Y; Liu J; Liang Z; Pi Y; Su Z; Chen D; Guo L; Jiang Q; Yang L; Wang Y
    Respiration; 2022; 101(9):859-868. PubMed ID: 35790142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.
    Sibila O; Garcia-Bellmunt L; Giner J; Rodrigo-Troyano A; Suarez-Cuartin G; Torrego A; Castillo D; Solanes I; Mateus EF; Vidal S; Sanchez-Reus F; Sala E; Cosio BG; Restrepo MI; Anzueto A; Chalmers JD; Plaza V
    Ann Am Thorac Soc; 2016 May; 13(5):636-42. PubMed ID: 26882402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.
    Röpcke S; Holz O; Lauer G; Müller M; Rittinghausen S; Ernst P; Lahu G; Elmlinger M; Krug N; Hohlfeld JM
    PLoS One; 2012; 7(10):e46207. PubMed ID: 23056262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptase enzyme activity is correlated with severity of chronic obstructive pulmonary disease.
    Zhang X; Zheng H; Ma W; Wang F; Zeng X; Liu C; He S
    Tohoku J Exp Med; 2011 Jul; 224(3):179-87. PubMed ID: 21685721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
    Lim EY; Song EJ; Shin HS
    J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
    Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
    COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The elevated CXCL5 levels in circulation are associated with lung function decline in COPD patients and cigarette smoking-induced mouse model of COPD.
    Chen J; Dai L; Wang T; He J; Wang Y; Wen F
    Ann Med; 2019; 51(5-6):314-329. PubMed ID: 31269827
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral microbial dysbiosis in patients with periodontitis and chronic obstructive pulmonary disease.
    Liu S; Xie G; Chen M; He Y; Yu W; Chen X; Mao W; Liu N; Zhang Y; Chang Q; Qiao Y; Ma X; Xue J; Jin M; Guo S; Hou Y; Gao Z
    Front Cell Infect Microbiol; 2023; 13():1121399. PubMed ID: 36844402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.
    Cabrera-Rubio R; Garcia-Núñez M; Setó L; Antó JM; Moya A; Monsó E; Mira A
    J Clin Microbiol; 2012 Nov; 50(11):3562-8. PubMed ID: 22915614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between expression of matrix metalloproteinase-9 and adenylyl cyclase-associated protein 1 in chronic obstructive pulmonary disease.
    Xie SS; Hu F; Tan M; Duan YX; Song XL; Wang CH
    J Int Med Res; 2014 Dec; 42(6):1272-84. PubMed ID: 25332229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study.
    Xue Q; Xie Y; He Y; Yu Y; Fang G; Yu W; Wu J; Li J; Zhao L; Deng X; Li R; Wang F; Zheng Y; Gao Z
    Sci Rep; 2023 Apr; 13(1):5715. PubMed ID: 37029178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
    Su L; Qiao Y; Luo J; Huang R; Xiao Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COPD and the microbiome.
    Mammen MJ; Sethi S
    Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17/Treg balance and gut-lung axis microbiota.
    Jia Y; He T; Wu D; Tong J; Zhu J; Li Z; Dong J
    J Transl Med; 2022 Jun; 20(1):281. PubMed ID: 35729584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease.
    Brajer-Luftmann B; Nowicka A; Kaczmarek M; Wyrzykiewicz M; Yasar S; Piorunek T; Grabicki M; Kostrzewska M; Sikora J; Batura-Gabryel H
    Adv Exp Med Biol; 2019; 1113():27-35. PubMed ID: 29429028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
    Opron K; Begley LA; Erb-Downward JR; Freeman C; Madapoosi S; Alexis NE; Barjaktarevic I; Graham Barr R; Bleecker ER; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper DJ; Doerschuk CM; Dransfield MT; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kaner RJ; Krishnan J; O'Neal WK; Ortega VE; Paine R; Peters SP; Michael Wells J; Woodruff PG; Martinez FJ; Curtis JL; Huffnagle GB; Huang YJ
    NPJ Biofilms Microbiomes; 2021 Feb; 7(1):14. PubMed ID: 33547327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.